Stem Holdings, Inc. Begins Trading on the Canadian Securities Exchange Under Ticker Symbol “STEM”
July 16 2018 - 12:30PM
Stem Holdings, Inc. (“
Stem” or the
“
Company”) (OTCQB: STMH; CSE: STEM) is pleased to
announce that its common shares have begun trading under the ticker
symbol “STEM” on the Canadian Securities Exchange (the
“
CSE”).
Stem is an innovative real estate company,
which acquires and improves properties for the cannabis industry.
Stem owns multiple licensed cultivation facilities and retail
stores in Oregon and Nevada. The Company has also developed
partnerships with a number of award-winning cannabis
brands.
“Listing on the CSE provides Stem access to
capital to fund the Company’s strategy for growth and leverage our
position as a leader in the cannabis industry,” said Stem’s CEO,
Adam Berk. “We are excited to provide an opportunity for global
investors to participate in our expansion strategy that focuses on
multiple sectors of the market, while still providing value to our
current shareholders.”
A listing statement with information about Stem
and prepared in accordance with the policies of the CSE will be
available on SEDAR at www.sedar.com.
About Stem Holdings, Inc.
Stem has positioned itself as a leader in the U.S. cannabis
industry by building state-of-the-art licensed solutions,
including: cultivation, processing and retail properties across
multiple U.S. markets. As an innovative real estate company, Stem
acquires and improves properties for the cannabis industry. Stem
has set itself apart by building and partnering with a variety of
marijuana-based businesses, from edibles to hemp cultivation. The
Company has developed an extensive portfolio of award-winning
consumer-facing brands, partnering with well known, branded
cannabis operators with a proven track record of success, such as
TJ’s Gardens, Cannavore, incredibles, Doseology and Green T-Farms.
For more information, visit www.stemholdings.com.
Cautionary Note Regarding Forward-Looking
Information
This press release contains statements which constitute
“forward-looking information” within the meaning of applicable
securities laws, including statements regarding the plans,
intentions, beliefs and current expectations of the management of
Stem with respect to future business activities. Forward-looking
information is often identified by the words “may”, “would”,
“could”, “should”, “will”, “intend”, “plan”, “anticipate”,
“believe”, “estimate”, “expect” or similar expressions and include
information regarding: (i) the ability of the Company to
successfully achieve its business objectives, (ii) plans for
expansion of Stem, and (iii) expectations for other economic,
business, and/or competitive factors.
Investors are cautioned that forward-looking information is not
based on historical facts but instead reflect the management of
Stem’s expectations, estimates or projections concerning future
results or events based on the opinions, assumptions and estimates
of management considered reasonable at the date the statements are
made. Although Stem believes that the expectations reflected in
such forward-looking information are reasonable, such information
involves risks and uncertainties, and undue reliance should not be
placed on such information, as unknown or unpredictable factors
could have material adverse effects on future results, performance
or achievements of the Company. Among the key factors that could
cause actual results to differ materially from those projected in
the forward-looking information are the following: changes in
general economic, business and political conditions, including
changes in the financial markets; and in particular in the ability
of the Company to raise debt and equity capital in the amounts and
at the costs that it expects; adverse changes in the public
perception of cannabis; decreases in the prevailing prices for
cannabis and cannabis products in the markets that the Company
operates in; adverse changes in applicable laws; or adverse changes
in the application or enforcement of current laws, including those
related to taxation; the inability to locate and acquire suitable
companies, properties and assets necessary to execute on the
Company’s business plans; and increasing costs of compliance with
extensive government regulation. This forward-looking information
may be affected by risks and uncertainties in the business of Stem
and market conditions.
Should one or more of these risks or uncertainties materialize,
or should assumptions underlying the forward-looking information
prove incorrect, actual results may vary materially from those
described herein as intended, planned, anticipated, believed,
estimated or expected. Although Stem has attempted to identify
important risks, uncertainties and factors which could cause actual
results to differ materially, there may be others that cause
results not to be as anticipated, estimated or intended. Stem does
not intend, and does not assume any obligation, to update this
forward-looking information except as otherwise required by
applicable law.
No securities regulatory authority has in any way passed upon
the merits of the proposed transactions described in this news
release or has approved or disapproved of the contents of this news
release.
For further information, please contact:
Investor Relations Contact:
Amato and Partners, LLC
Investor Relations Counsel
212.460.0360
admin@amatopartners.com
Media Contact:
Mauria Betts
Director of Branding and Public Relations
(971) 266-1908
mauria@stemholdings.com
Microbot Medical (NASDAQ:MBOT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Microbot Medical (NASDAQ:MBOT)
Historical Stock Chart
From Apr 2023 to Apr 2024